University of Melbourne
Melbourne, Victoriaunimelb.edu.au
Overview
The University of Melbourne acts as a strategic investor in companies that spin out of its research and affiliate ecosystem. It has participated directly in funding rounds for companies like Synchron and Apromore. In 2022, the university formalized and expanded its investment activities by co-founding two dedicated venture capital funds: the A$125 million Tin Alley Ventures fund for seed to pre-IPO investments, and the A$15 million Genesis Pre-Seed Fund for very early-stage ideas. Tin Alley Ventures is a joint venture with Tanarra Capital, and the Genesis Fund is a partnership with Breakthrough Victoria. The university is an investor (LP) in these funds.
Portfolio Companies
17
Website
unimelb.edu.auInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cadmus | Sep 2025 | Seed | Co-investor |
| Flowing Bee | Mar 2025 | Pre Seed | Co-investor |
| Kali Healthcare | Oct 2024 | Grant | Co-investor |
| Porous Lane | Oct 2024 | Seed | - |
| Cell Bauhaus | Oct 2024 | Seed | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
